The downregulated NUCB1 in our COVID-19 patients suggested a harmful effect related to type 2 diabetes as it performs amyloid stabilization in human islet cells to prevent fibrils in the pancreas that impact type 2 diabetes [104, 139, 140]. The gene discussed is NUCB1; the disease is COVID-19.